BIOS Fund II NT, LP
SEC CIK 1728851 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INAB | IN8BIO, INC. | Dir, 10% | 562.0K | $147.0K | — | 3 | 2021-08-03 | 2022-09-28 |
Most active insiders at INAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rochlin Kate | COO | — | — |
| 2 | McCall Patrick | CFO | — | — |
| 3 | Ho William Tai-Wei | Pres AND CEO, Dir, 10% | — | — |
| 4 | FAIRBAIRN EMILY | Dir | — | — |
| 5 | Roemer Alan S. | Dir | — | — |
| 6 | Brandt Peter C. | Dir | — | — |
BIOS Fund II NT, LP made no open-market trades at INAB in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-09-29 | 2022-09-28 | INAB | IN8BIO, INC. | BIOS Fund II NT, LP | Dir, 10% | P - Purchase | $2.02 | +25.0K | 562.0K | +5% | +$50.5K |
| MI | 2022-08-18 | 2022-08-17 | INAB | IN8BIO, INC. | BIOS Fund II NT, LP | Dir, 10% | P - Purchase | $1.93 | +50.0K | 553.1K | +10% | +$96.5K |
| DMI | 2021-08-03 | 2021-08-03 | INAB | IN8BIO, INC. | BIOS Fund II NT, LP | 10% | C - Cnv Deriv | — | +6.63M | 1.88M | New | — |
Purchase Sale Sale after option exercise All abbreviations